<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30150038</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1872-7727</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>106</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>09</Month>                    </PubDate>                </JournalIssue>                <Title>European journal of radiology</Title>                <ISOAbbreviation>Eur J Radiol</ISOAbbreviation>            </Journal>            <ArticleTitle>Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System.</ArticleTitle>            <Pagination>                <MedlinePgn>150-159</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0720-048X(18)30265-1</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejrad.2018.07.026</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE">To assess imaging phenotypes of familial breast cancer on mammography (MG), ultrasound (US), and magnetic resonance imaging (MRI) using the fifth edition of the BI-RADS; to investigate inter-observer agreement and to correlate imaging phenotypes with risk status, histopathology, and molecular subtypes derived by immunohistochemical surrogate.</AbstractText>                <AbstractText Label="MATERIALS AND METHODS">Forty-nine women (BRCA-1/2 mutation carriers and women with &gt;20% lifetime risk) were diagnosed with breast cancer within our high-risk screening program. BI-RADS MG, US, and MRI imaging descriptors were correlated with risk status, histopathology, and molecular subtypes derived by immunohistochemical surrogate. Inter-rater agreement for BI-RADS MG, US, and MRI categories was assessed.</AbstractText>                <AbstractText Label="RESULTS">Fifty-two breast cancers were diagnosed and 98% were detectable in at least one modality. MRI detected more cancers (P &lt; 0.001). No lesion had benign morphology on BI-RADS. BRCA-1 had triple-negative and high-grade tumors in the posterior part and in the upper-outer quadrant (P ≤ 0.01); positive-family-history patients had intermediate-grade neoplasms (P &lt; 0.01) in the middle part (P = 0.04) and in the upper-outer quadrants (P = 0.05). There was moderate inter-rater agreement for the assigned BI-RADS assessment for MG (k = 0.554) and MRI (k = 0.512) and substantial inter-rater agreement for US (k = 0.741).</AbstractText>                <AbstractText Label="CONCLUSIONS">Imaging phenotypes of familial breast cancers with BI-RADS are malignant in all imaging modalities. Risk status seems to influence cancer location.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Marino</LastName>                    <ForeName>Maria Adele</ForeName>                    <Initials>MA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria; Department of Biomedical Sciences and Morphologic and Functional Imaging, University of Messina, Via Consolare Valeria 1, 98100, Messina, Italy. Electronic address: mariaadele.marino@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Riedl</LastName>                    <ForeName>Christopher C</ForeName>                    <Initials>CC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Molecular Imaging and Therapy Service, 1275 York Ave, New York, NY 10065,USA. Electronic address: riedlc@mskcc.org.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bernathova</LastName>                    <ForeName>Maria</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Electronic address: maria.bernathova@meduniwien.ac.at.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bernhart</LastName>                    <ForeName>Clemens</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Electronic address: clemensbernhart@hotmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Baltzer</LastName>                    <ForeName>Pascal A T</ForeName>                    <Initials>PAT</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Electronic address: pascal.baltzer@meduniwien.ac.at.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Helbich</LastName>                    <ForeName>Thomas H</ForeName>                    <Initials>TH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Electronic address: thomas.helbich@meduniwien.ac.at.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pinker</LastName>                    <ForeName>Katja</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria; Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66th Street, New York, NY, 10065, USA. Electronic address: katja.pinker-domenig@meduniwien.ac.at.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Ireland</Country>            <MedlineTA>Eur J Radiol</MedlineTA>            <NlmUniqueID>8106411</NlmUniqueID>            <ISSNLinking>0720-048X</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">BRCA1 Protein</Keyword>            <Keyword MajorTopicYN="Y">BRCA2 Protein</Keyword>            <Keyword MajorTopicYN="Y">Breast Neoplasms</Keyword>            <Keyword MajorTopicYN="Y">Magnetic resonance imaging</Keyword>            <Keyword MajorTopicYN="Y">Mammography</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>29</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>29</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>29</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30150038</ArticleId>            <ArticleId IdType="pii">S0720-048X(18)30265-1</ArticleId>            <ArticleId IdType="doi">10.1016/j.ejrad.2018.07.026</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>